Media playback is unsupported on your device

AstraZeneca boss: Pfizer bid 'could delay drug development'

13 May 2014 Last updated at 18:28 BST

The chief executive of AstraZeneca has warned that new drug development could be hit if it was taken over by Pfizer.

Pascal Soriot told BBC News that a takeover would create huge disruption.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.